[1]CurrentPatentAssignee:SERVIERMONDE-US2004/63972,2004,A1Locationinpatent:Page4
[2]CurrentPatentAssignee:SERVIERMONDE-US2004/59135,2004,A1Locationinpatent:Page2
[3]CurrentPatentAssignee:GLENMARKPHARMACEUTICALSLTD-US2012/123131,2012,A1Locationinpatent:Page/Pagecolumn8
[1]CurrentPatentAssignee:SERVIERMONDE-US2004/63972,2004,A1Locationinpatent:Page4
[1]CurrentPatentAssignee:GLENMARKPHARMACEUTICALSLTD-WO2010/21000,2010,A2Locationinpatent:Page20-21
[2]CurrentPatentAssignee:GLENMARKPHARMACEUTICALSLTD-US2012/123131,2012,A1Locationinpatent:Page/Pagecolumn8
[1]CurrentPatentAssignee:GLENMARKPHARMACEUTICALSLTD-WO2010/21000,2010,A2Locationinpatent:Page19-20
[1]CurrentPatentAssignee:FLEMINGLAB-WO2013/175270,2013,A1Locationinpatent:Page/Pagecolumn18
Title: Synthesis and SAR studies of 1,4-benzoxazine MenB inhibitors: novel antibacterial agents against Mycobacterium tuberculosis.
Journal: Bioorganic & medicinal chemistry letters 20101101